Arcutis Biotherapeutics (ARQT) announced the Free to Be Me awareness campaign featuring actress Tori Spelling, and her daughter, Stella. The campaign aims to shed light on the emotional and physical burden of inflammatory skin diseases for the approximately 36 million Americans living with conditions such as atopic dermatitis and seborrheic dermatitis – and to inspire people to work with their healthcare providers to find long-term treatment options for their chronic skin diseases.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARQT:
- Arcutis Biotherapeutics announces commercial launch of ZORYVE cream
- Arcutis Biotherapeutics price target raised to $29 from $19 at Goldman Sachs
- Arcutis Biotherapeutics price target raised to $32 from $26 at Mizuho
- Arcutis Biotherapeutics price target raised to $30 from $22 at H.C. Wainwright
- Arcutis Biotherapeutics Reports Strong Q3 Earnings Call